PSMA-ALB-56 is a PSMA-targeting radioligand designed by combining the glutamate-urea PSMA-binding entity and an albumin binderIn VivoPSMA-ALB-56 accumulates much faster in tumor tissues and is more efficiently cleared from the blood and background tissues, which results in excellent tumor-to-background contrast already 4 hours after injection. PSMA-ALB-56 increases median survival in mice . MCE has not independently confirmed the accuracy of these methods. They are for reference only.Form:SolidIC50& Target:Traditional Cytotoxic Agents.
Specifications and Purity: ≥98%
Molecular Formula: C66H95N11O18
Molecular Weight: 1330.52
- UPC:
- 41114404
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- P650605-1mg
- CAS:
- 2306049-48-7
- Product Size:
- 1mg
akash.verma@cenmed.com
(732) 447-1115





